Per the FDA guidance, an electronic consent is any “the use of electronic systems and processes that may employ multiple electronic media to obtain informed consent for both HHS-regulated human subject research and FDA-regulated clinical investigations of medical products, including human drug and biological products, medical devices, and combinations thereof.”  

eConsent is gaining greater acceptance and adoption in clinical trials

  • 90% of top 10 pharma have an eConsent initiative in place
  • 88% of top 25 pharma implemented eConsent
  • 66% of top 50 pharma companies are engaged in planning an eConsent initiative

Every clinical trial is different, but implementing the right eConsent solution will improve your clinical trial startup through improved patient understanding, site satisfaction, and regulatory compliance.

96% of clinical trial participants that have used eConsent, prefer it over paper informed consent.

  • Gaining popularity and higher satisfaction with elderly participants
  • Combining multi-media with quiz aids better information
  • More accurate, improves comprehension and makes better clinical trial patients

77% of sites mentioned that eConsent has improved patient consent and site startup.

  • Improves time spent with patients
  • Quickly address questions and responses to patients
  • Better compliance and controlled document management

Delve Health’s Clinical StudyPal is a decentralized platform that can help engage sponsors, investigative sites, and patients. Collect the most pertinent information. We help improve patient compliance in clinical trials, create better consent modules, and integrate with EDC/CTMS/eTMF/Wearables for better clinical trial conduct.

Big pharma is already embracing eConsent. You can get the same benefits by talking with our experts at Delve Health. Reach out and talk to our experts on how to implement a cost-effective eConsent solution for your upcoming clinical trial.  

Click here to schedule a call or call one of our experts at the numbers below

Delve Health   https://www.delvehealth.com


Delve Health Provides the Technology Platform to Design Clinical Trials to Fit a Patient’s Lifestyle—Not the Other Way Around

A significant number of companies announced delays and cancellations to planned and on-going clinical trials because of COVID-19 lockdowns and social distancing measures. There
real-time outcomes

Remote Patient Monitoring in Clinical Trials

In 1958, AT&T came out with the Bell 101 modem—the first commercial modem to transmit data via what would later be known as “the
Screen Shot Clinical researcher

Opinion: We Have Been Gifted a New Outlook on Increasing Patient Diversity, Compliance, and Retention in Clinical Trials

ACRP Clinical Researcher—June 21, 2022 Our own co-founder and CEO of Delve Health, Wessam Sonbol was published in the ACRP Clinical Researcher magazine. The
Patient Reported Outcomes

Conversations On the Ground—Traditional CROs vs. Virtual CROs

Delve Health’s upper management is currently attending the Drug Information Association’s (DIA) 2022 Global Annual Meeting in Chicago, Illinois. While we are taking all
Screen Shot afortiori development

Delve Health and Afortiori Development Announced Their Collaboration. What Does it Mean for Clinical Research?

Delve Health, a clinical research technology firm, and Afortiori Development, a clinical contract research organization (CRO), have announced an exciting partnership to expand patient
clinical trail day screenshot

Clinical Trials Day

May 20, 2022—Today is Clinical Trials Day. A day to recognize and raise awareness as to why clinical trials are so important to all